INTRODUCTION
Transgenic, or genetically modified, crops are now a common feature of the agricultural landscape of North America, though in certain parts of Europe there is still great reluctance to accept their introduction. Despite this uncertainty, the potential of this technology is very evident to the commercial world, and a great range of experimental material is being tested, both in the laboratory and under field conditions (Table 1) . This review will not summarize all the various transgenic varieties now grown, or approved for sale, nor will it discuss all the improved agronomic characteristics under study. Instead it will concentrate on those experimental approaches likely to reach the market in the next 10-20 years with particular attention paid to added-value or quality traits. It is obvious that the commercial trends (Hitz, 1999) are towards vertical integration with a rapid movement of interest from the first generation of single gene traits, such as herbicide tolerance and insect resistance, towards the second generation of transgenics where the emphasis has moved to product quality and multiple gene inserts (Table 1) . Specifically, this review will predict the type of transgenic plant products that will become available commercially in the year 2020. It should be stressed that the time scale for the commercialization of transgenic crops (Dunwell, 1996) is as lengthy as any other variety ; the tomato puree first sold in the UK in 1996 was developed from an academic project dating back to the early 1980s.
THE VISION
In this section the various types of transgenic product will be considered in sequence, according to their applications in the environment, in industry, in the home, as foodstuffs E-mail J.Dunwell!reading.ac.uk (Dunwell, 1998 b) , or in medicine\veterinary medicine. It will use information not solely from the usual scientific journals but will include much information obtained from analysis of patent databases (eg : US Patent Office at http :\\patents.uspto.gov\access\search-adv.html, an extensive site supported by IBM at http :\\www. patents.ibm.com\, a World Intellectual Property Organization database at http :\\pctgazette.wipo.int\ and a site provided by Derwent, one of the major commercial providers of patent information, at http :\\www.derwent. co.uk\plweb-cgi\fastweb?searchformjview1) and the databases listing the field trial applications in the USA (http :\\www.aphis.usda.gov\bbep\bp\database.html. and summarized versions at http :\\www.nbiap.vt.edu\cfdocs) ( Table 1 ). All these sites are free and have searchable databases which can provide either summary details or, in T  1. Summary of data for US field trial applications at 3 year inter als, 1987-1999, subdi Category 1987 Category 1990 Category 1993 Category 1996 Category 1999 Herbicide tolerance  67  22  33  24  24  Insect resistance  22  21  22  23  9  Virus resistance  11  29  16  16  -Bacterial resistance  -5  2  1  -Fungal resistance  -4  4  8  6  Agronomic properties  -3  2  3  6  Product quality  -8  18  17  52  Marker genes  -3  1  3  -Nematode resistance  --1  --Other  -6  2  5  3 Values given are the percentages of applications in each category. For more details of the database, see text 0305-7364\99\090269j09 $30.00\0
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# 1999 Annals of Botany Company some cases, images of complete applications. Both sources of information are of great value in a predictive analysis of the type attempted here since they provide a view of commercial intentions not often available to the academic scientist.
Within the overall context of this review, the advantages of using plants as an expression system for valuable proteins (Hebers and Sonnewald, 1999) can be considered to be the low cost of biomass production, the presence of established methods for harvesting and processing, storage stability and the occurrence of posttranslational processing. Some of these aspects will be discussed in more detail below.
En ironment
Although most transgenic plants are being developed for growth under agricultural conditions, one specific type of transgenic plant has greater value in a more general environmental context, namely as a means of bioremediation-that is the decontamination of land either naturally polluted or contaminated as a consequence of industrial or other activity. Amongst the examples of this type is the use of transgenic yellow poplar (Liriodendron tulipifera) which express the bacterial mercuric reductase gene (Rugh et al., 1998) . Such transgenics grew vigorously in media containing normally toxic levels of ionic mercury, and released elemental mercury at approximately ten times the rate of untransformed controls. Related examples of plants that may be suitable for ' phytoremediation ' include mustard with increased tolerance to cadmium (Zhu et al., 1999) , tobacco expressing various enzymes capable of degrading hydrocarbon pollutants, and a proposal to use trees overexpressing nitrate reductase to remove the oxides of nitrogen found in inner cities.
Industry
Biomass\fuel. As part of the increasing interest in the development of sustainable agricultural systems, several new types of biomass crop are being investigated. These include rapidly growing trees (e.g. poplar and eucalyptus) to be used as feedstocks for power stations or for producing other fuel products such as ethanol. Amongst the many transgenic plants being tested for this application are those which either overexpress cellulose synthase genes (Arioli et al., 1998) and those that have an indirect benefit by overexpressing cellulases used in the conversion of cellulosic biomass to ethanol (Lebel et al., 1998) . For a general discussion of the possible modification of the plant cell wall, the reader is referred to Chapple and Carpita (1998) .
Lignin\paper. The major commercial value of cellulose is as a raw material for paper manufacture and it has been known for several years that the efficiency of the pulping process could be affected by the alteration of enzymes (e.g. cinnamyl alcohol dehydrogenase-CAD) involved in the synthesis of lignin-the complex heteropolymer which must be separated from the cellulose fibres during pulping (see Bauscher et al., 1998) . There are now many field trials and preliminary pulping tests being conducted on transgenic trees with modified lignins (Lapierre et al., 1999) , and such studies have revealed a significant benefit of reduced-CAD plants in terms of the ease of lignin solubilization and fragmentation. Since ' kraft ' pulping is such an energy intensive process this improvement in cellulose extraction would have major economic benefits if confirmed in full scale trials. An incidental difference found in such transgenic trees is a change in colour of the wood produced. Instead of the usual pale colour, the wood of many transgenics has a mottled or red-brown colouration due to the accumulation of coniferyl aldehyde residues (Tsai et al., 1998) . It has been proposed (Higuchi et al., 1994) that this coloured wood could have advantages in furniture manufacture since it would not require any staining.
Plastics. There has been much interest in the last few years in the concept of using plants to produce high value polymeric compounds including carbohydrates (Heyer, Lloyd and Kossmann, 1999) and biodegradable plastics (Poirier, 1999) . The former group include non-calorific sweeteners such as fructan which has now been produced in transgenic sugar beet (Se! venier et al., 1998 ) (see food section below), whereas most emphasis in the latter group has been placed on the polyhydroxyalkanoates (PHA) (Madison and Huisman, 1999 )-polyesters of 3-hydroxyacids. The first PHA produced in plants was the homopolymer polyhydroxybutyrate (PHB), a compound derived from acetylCoA which is found in several subcellular compartments including cytoplasm, plastids and peroxisomes. In the most recent report (Poirier, 1999) it is claimed that Monsanto now have transgenic oilseed rape plants which express PHB in the leucoplasts of developing embryos at the level of 8 % of dry weight of mature seed. This polymer has also been expressed in the lumen of cotton fibre (John, 1997 ; Chowdhury and John, 1998 ) (see below).
Although this review will not consider in any detail the various production systems for plant-derived products (see Owen and Pen, 1996) there are several novel approaches that deserve mention. Amongst these is the proposed use of rubber trees as a continuous producer that can literally be tapped at regular intervals. This concept is demonstrated by the success achieved in expressing the GUS protein in the latex, and more importantly in the serum fraction, of transgenic trees (Arokiaraj et al., 1998) . In principal therefore, any protein could be produced at high level in this exudate, and harvested easily. An additional advantage of this system is the efficient vegetative propagation of the transgenic material. This is of benefit in terms of rapid establishment of a commercial production system, as well as in preventing any unintentional spread of the transgene through seed or pollen.
Terpenoids. Essential oils are valuable plant-derived compounds used extensively for flavouring, perfume production and in medicine. Their aromatic qualities are a feature of monoterpenes, and to a lesser extent the sesquiterpenes, both chemicals that belong to the isoprenoid group of structurally diverse compounds. The high commercial value of these products is shown by the estimated farm gate value for mint oil of $160 million, a figure that increases to $5n5 billion for the processed products derived from it (quoted in Lange and Croteau, 1999). Until recently, little was known about the genetic control of the metabolic pathways for these compounds, but many of these genes have now been characterized. For example, construction of a cDNA library from the oil gland secretory cells of peppermint has allowed the sequencing of genes encoding 1-deoxy-5-xylulose-5-phosphate (DXP) synthase, DXP reductoisomerase, isopentyl diphosphate isomerase, geranyl diphosphate synthase, farnesyl diphosphate synthase, geranylgeranyl diphosphate synthase, limonene synthase, and limonene-6-hydroxylase. This project has also revealed candidate genes with homologies to dehydrogenases, kinases, dehydratases, isomerases, acyl transferases, and glycosyl transferases. One specific objective of this programme is the manipulation of p-menthane monoterpene metabolism in peppermint by overexpression of the dehydrogenase that converts (minus)-menthone to (minus)-menthol (Lange and Croteau, 1999) . Another, related approach to modifying the synthesis of such essential oils is to increase the density of the mint glandular trichomes, the specialized cells in which the oils are produced and stored. In the near future therefore, there will be a range of transgenic approaches to generate improved yields of desirable flavour and fragrance compounds, or to reduce the levels of undesirable compounds.
Household
Clothing. Of all the non-food crops for which transgenic methods have been developed, possibly the most interesting is cotton (John, 1997) . Apart from the existing herbicide and insect resistant (approx. 40 % of all insecticides are used on cotton) varieties which are now grown widely in the USA, there are many other experimental approaches being developed. These include the introduction of pigment compounds (e.g. melanin for black colouration) produced in the lumen of the cotton fibre (a single cell composed mostly of cellulose) under the control of fibre-specific promoters, and the synthesis of plastics such as polyhydroxybutyrate (Hankermeyer and Tjeerdema, 1999 ; Poirier, 1999) in the same cells. The coloured fibres would obviate the need for the dying of cotton-often an environmentally damaging process-whereas fibres containing a plastic core have improved thermal properties as estimated by a higher heat capacity and a lower thermal conductance (Chowdhury and John, 1998) , and could be incorporated into insulating clothing.
A distantly related approach to improving clothing quality is represented by the concept of introducing sulphurcontaining proteins into forage crops as a means of increasing the growth rate of wool on sheep grazing on such transgenic pasture (Tabe et al., 1995) .
Garden plants\ornamentals. Although GM flowers have been available commercially since 1996, this area of transgenic plant production is often overlooked. The first such plant was Moondust4, a mauve-coloured carnation variety obtained by the introduction, into a white variety, of genes encoding flavonoid 3h,5h-hydroxylase (capable of hydroxylation of the anthocyanin B-ring), and dihydroflavonol 4-reductase. This new transgenic variety accumulated delphinidin rather than the dihydrokaempferol of the original white form. In addition to this, and related varieties with modified colours, regulatory approvals have also been granted for the marketing of carnations with enhanced vase life (generated by the antisense down-regulation of an ethylene biosynthesis gene). In a related experiment, it has recently been reported (Hirschberg, 1999) that the introduction into tobacco of a crtO gene (encoding β-C-4-oxygenase) from the alga Haematococcus plu ialis led to the accumulation of high levels of ketocarotenoids, including astaxanthin (used as a colourant in food for farmed fish), in the chromoplasts of the floral nectaries, thus changing their colour from yellow to red. It is can be assumed that such modified flower crops (Mol et al., 1999) , will be widespread by the time of this review period.
Food and Drink
For a general summary of this area of development the reader is referred to Dunwell (1998 b) .
Protein composition. Modification of protein quality can be approached either from the perspective of changing the amino acid composition of a single protein in order to improve its value, or from the concept of adding an entirely new protein (perhaps with associated down-regulation of the existing protein). Examples of the former approach include increasing the amount of nutritionally-limiting amino acids such as methionine in potato (Tu, Godfrey and Sun, 1998) and functional modification of the glycinin protein from soybean (Utsumi et al., 1997) . The latter method has been used to modify wheat, where the baking quality is dependent to a large extent on the type of highmolecular-weight glutenin subunits found in the flour. These proteins determine the strength and elasticity of the dough, and seeds of a typical bread wheat cultivar contain 4-5 subunits. It has now been shown that the manipulation of these subunits is possible in transgenic plants (Blechl, Hung and Anderson, 1998) , with resultant benefits in baking quality. Possibly the best example of this is the addition of subunits to a variety with only two native subunits, with an improvement in the dough quality in the transgenic (Barro et al., 1997) .
One of the most interesting specialist uses of transgenic crops for human nutrition is that of expressing various human milk proteins in edible plants. For example, it has been shown that the gene encoding the beta-casein protein can be introduced into potato under the control of an auxininducible promoter and that the human protein can be detected in the leaves and tubers of the transgenic plants at a level of 0n01 % soluble protein (Chong et al., 1997) . Similarly, the human alpha-lactalbumin (Takase and Hagiwara, 1998) and lactoferrin (Salmon et al., 1998) proteins have been expressed in transgenic tobacco. These findings provide the basis for the reconstitution of human milk in plants as a replacement for bovine milk in baby foods which are used either for the general improvement of infant nutrition or for the prevention of gastric and intestinal diseases in children. In addition, lactoferrin is a multifunctional protein which is thought to have antibacterial, antifungal, and antiviral properties. Other proposed functions for this protein include promotion of lymphocyte growth, stimulation of cytokine production and activation of the immune system, inhibition of mammary cell growth, reduction of platelet aggregation, and activation of NK cells (for references, see Salmon et al., 1998) .
Starch and oil. Advances in these two areas are relatively well-known with the proven ability to modify the specific degree of branching in carbohydrates (Heyer et al., 1999) and to alter the degree of saturation and chain length in oils and lipids (Murphy, 1999) . Some of these transgenic varieties producing designer oils for industrial use in detergents and lubricants are not far from commercialization. In addition, particular high value oils with claimed health benefits can now be produced at reasonable levels in heterologous plants (Sayanova et al., 1997) .
Vitamins. Although vitamin deficiency is rare in the developed world, there are still large numbers of people in developing countries whose diet is deficient in vitamins or other micronutrients. For example, it is estimated that over 124 million children worldwide are deficient in vitamin A (carotenoids), and that improvement in their dietary intake of this vitamin could prevent 1n3-2n5 million deaths among infants and pre-school children (quoted in Hirschberg, 1999) . One approach to this problem is the introduction of the psy gene, encoding the enzyme phytoene synthase, into crops that are deficient in vitamin A. This enzyme catalyses the head to head condensation of two geranylgeranyl diphosphate molecules to produce phytoene, the precursor of lycopene which itself is converted to carotenoids. The validity of this strategy has been confirmed by the successful expression of the daffodil psy gene in rice, leading to the accumulation of provitamin A in the endosperm (Burkhardt et al., 1997 ). An improved understanding of the biosynthetic pathway for vitamin C has also led to claims for its overexpression in plants. For example, it was suggested (Bauw et al., 1998) that the level of this vitamin can be increased by expressing the gene encoding the L-galactono-α-lactone dehydrogenase enzyme.
Micronutrients. Amongst the various micronutrient deficiencies in diets, probably the most significant is that for iron. It is estimated that such deficiency affects about 30 % of the world population, particularly in areas where vegetable diets are predominant. Although it is possible to increase the iron content of crops by enriching the soil, this method is both costly and imprecise. An alternative approach is exemplified by the recent results obtained by introducing into rice a gene encoding the soybean ferritin -an iron-storage protein. When this gene was expressed under the control of a rice seed-storage protein promoter, the levels of iron in the endosperm of the transgenic seeds was increased threefold compared to the controls (Goto et al., 1999) . Other aspects of this approach have been discussed elsewhere (Schachtman and Barker, 1999) .
Allergens\toxins. The feasibility of using transgenic techniques to reduce the levels of allergens in foodstuffs has been proved by the successful reduction of the allergenic 14-16 kDa protein in rice (Nakamura and Matsuda, 1996) . A similar approach is now being adopted to reduce the levels of one or more of the allergenic proteins (eg AraH1) in peanut, accidental consumption of which is a regular cause of death from anaphylactic shock. The probability of success of this strategy has increased recently following the detailed analysis of the specific allergenic domains within the protein (Shin et al., 1998) , its relationship to other seed storage proteins , together with the development of reliable transformation techniques for this crop. The importance of assessing the allergenicity of all novel transgenic food products is well known, particularly in those cases involving modification of protein quality or quantity. In this context, it is somewhat ironic that the increased popularity of ' natural ' vegetable oils that have undergone less processing is actually increasing the risk of exposure to potentially allergenic proteins that are not removed during the refinement procedure (Teuber, Brown and Haapanen, 1997 ; Olzewski et al., 1998) .
During the long history of plant breeding, there has been continuous selection of more palatable varieties, whether it be by the simple expedient of avoiding the toxic types, or by using the more accurate analytical methods now available. This procedure can now be hastened by the direct removal of compounds known to have deleterious properties. Amongst the best known of these is caffeine, there being a very large commercial market for caffeine-free drinks. It is now claimed (e.g. Stiles, Moisyadi and Neupane, 1998 ) that the antisense down regulation of xanthosine N7-methyltransferase can be used to reduce the level of caffeine in transgenic coffee.
Frozen food. One of the many myths perpetrated about GM food is that an antifreeze gene from the arctic flounder (Hightower et al., 1991) has been introduced into strawberries in order to improve their resistance to freezing, and that such material is already on the market-thus providing plenty of ammunition for the cartoonists and comments that consumers do not want their fruit and vegetables to taste of fish ! In reality, transgenic lines containing this and other antifreeze proteins (AFPs) have been generated (Duman, 1997 ; Wallis, Wang and Guerra, 1997) , but the greater long term opportunities lie with AFPs of plant origin, particularly those that are already in the food chain. This approach was recently demonstrated by the successful introduction into tobacco of an AFP from carrots (Worrall et al., 1998) . Expression of this gene is induced during the cold hardening process that occurs as plants become adapted to freezing conditions and in the case of carrot, accumulation of the AFP prevents ice crystal formation and subsequent destruction of the root in frozen soil.
Other additi es. In addition to the non-calorific sweeteners such as fructans (referred to above), other protein sweeteners such as monellin, mabinlin (Sun et al., 1997) and thaumatin (Fischer et al., 1998) have also been introduced into crops with the intention of improving the palatability of fruit and vegetables. It can also be predicted that future modifications will include other sweet and sweetness-inducing compounds such as the oleanane-type triterpene glycosides (strogins) isolated from leaves of Staurogyne merguensis (Sugita, Inoue and Kurihara, 1998) . Modification of other specific flavour components can be made by alterations such as those involving the levels of alcohol dehydrogenase (Speirs et al., 1998 Sehnke and Ferl, 1999 Beer. The ability to generate transgenic barley has been utilized in a number of brewing-related projects amongst which is one involving the modification of the glucanase enzyme as a means of improving the efficiency of the brewing process (Jensen et al., 1996) . In detail, the codon usage of a hybrid bacterial gene encoding a thermostable (1,3-1,4)-beta glucanase was modified to correspond to that of the barley gene encoding the related glucanase EII isoenzyme. When this modified bacterial gene was expressed in transgenic barley under the control of the barley high-pI alpha-amylase promoter, several of the transformants synthesized a thermostable form of glucanase during germination.
Another target for modification of brewing quality is the biosynthesis of proanthocyanidins, compounds responsible for ' haze ' in beer. It is claimed (Tanner, Joseph and Larkin, 1998 ) that introduction of the leucoanthocyanidin reductase gene improves malting quality. Table  2) Vaccines\antigens\antibodies. This area of application is one of those undergoing the greatest expansion at present, with several companies being established in order to exploit the potential benefits of reliable and economic methods for the plant-based production of vaccines and other medically related compounds. It should be noted that the general concept of plant-derived anti-viral vaccines is the subject of a US Patent granted in March 1997 to Edible Vaccines Inc. of Conroe, Texas (US Patent Number 5612487) and there are several other patent applications covering this subject.
Medical and eterinary applications (summarized in
Perhaps the best known series of studies on the efficacy of plant-derived antibodies and antigens (Ma and Vine, 1999) in human health is that conducted on Streptococcus mutans, the major cause of tooth decay. In the first approach (Curtiss and Cardineau, 1997) the gene encoding the cell surface-adhesion protein spa A or streptococcal antigen I\II was introduced into tobacco and expressed at levels of up to 0n02 % total leaf protein. Subsequently, most progress has been made with Guy's 13, a murine IgG1 monoclonal antibody that binds to the adhesion protein of S. mutans. In the most recent study it was shown that a monoclonal secretory version of this antibody could be produced in plants and that it afforded specific protection in humans against oral streptococcal colonization for at least 4 months (Ma et al., 1998) . In a similar study it has been shown that a soybean-derived, humanized anti-herpes simplex virus 2 (HSV-2) monoclonal antibody was similar to the mammalian cell line-derived version in terms of its stability in human semen and cervical mucus over 24 h, its ability to diffuse in such mucus and its efficacy in preventing vaginal HSV-2 infection in the mouse (Zeitlin et al., 1998) .
In any study designed to use such plant-derived recombinant glycoproteins for therapeutic purposes, it is most important to determine the extent to which glycans found in mammalian glycoproteins produced in plants differ from the natural version. In the first study of this type, CabanesMacheteau et al. (1999) compared the structures of the Nlinked glycans attached to the heavy chains of monoclonal antibody Guy's 13 produced in transgenic tobacco with those found in the corresponding IgGI of mouse origin. It was found that the number of glycoforms in the plant was higher than that from the mouse, a finding that suggests some possible concern about using plant-derived antibodies for systemic therapy, though topical application may not be a limitation.
The most widespread of autoimmune diseases is diabetes mellitus, a condition affecting millions worldwide. The type I form of the disease usually develops during childhood and is caused by T-cell mediated, irreversible destruction of the insulin-secreting cells of the pancreas. Its treatment involves daily injections of insulin, a procedure designed to regulate the levels of glucose in the blood ; if glucose levels are too high then non-specific protein glycosylation can occur, a process which often leads to nerve damage, blindness and a range of other life-threatening conditions. It is known that oral administration of disease-specific autoantigens can prevent or delay the onset of autoimmune disease symptoms. This information was first used in a successful experiment to test the effect of a plant-derived glutamic acid decarboxylase autoantigen (Ma et al., 1997) . This was followed by an experiment to test transgenic potatoes which expressed either human insulin (the major autoantigen) alone or a hybrid protein in which the insulin was linked to the Cterminus of the cholera toxin B subunit (CTB) in order to direct delivery of the plant-derived insulin to the gutassociated lymphoid tissue (Arakawa et al., 1998) . Nonobese diabetic mice fed tuber tissue containing microgramme amounts of the CTB-insulin fusion protein showed a significant reduction in pancreatic inflammation and a delay in the onset of diabetic symptoms.
As well as direct therapeutic applications, plant-derived antigens\antibodies are also being tested for use in diagnostic systems. For example, the human hepatitis B virus (HBV) core antigen has been expressed in tobacco, and the recombinant product used successfully in the haemagglutination test routinely conducted by the Japanese Blood Centre on blood samples from HBV positive donors (Tsuda et al., 1998) . The serological results were comparable with those achieved with the standard antigen from E. coli.
Considering veterinary applications, amongst the most important virus diseases of farm animals is swine-transmissible gastroenteritis virus (TGEV), the causative agent of acute diarrhoea of newborn piglets. Arabidopsis plants were transformed with constructs encoding either the N-terminal or full length glycoprotein S of TGEV and it has now been shown that mice immunized with leaf extracts from transgenic plants developed antibodies that reacted specifically to TGEV in ELISA, immunoprecipitated the virus-induced protein and neutralized the virus infectivity (Go! mez et al., 1998) . Similarly promising results have been achieved with transgenic alfalfa plants expressing the structural protein VP1 of foot and mouth disease (Carillo et al., 1998 ; Wigdorovitz et al., 1999) and it is claimed (Merot et al., 1997 ; Modelska et al., 1998) that the same approach can be adopted to express the rabies glycoprotein G.
In an extension of this approach, Smith, Walmsley and Polkinghorne (1997) suggested that plant-derived vaccines would have great potential value as a means of delivering oral immunocontraceptives to a wide range of herbivore species. Specifically, they propose the use of transgenic maize or carrots to deliver such vaccines to macropodids such as kangaroos and wallabies. The transgenic material would be distributed two or three times a year at watering points which have been fenced with special ' roo ' gates that allow the free movement of the target animals but restrict the entry of domestic sheep and cattle. In this way the uptake of vaccine by non-target species would be minimized.
Enzymes. Production of pharmaceutically active enzymes in plants is another rapidly expanding area of interest (Owen and Pen, 1996) , with the examples including orally active enzymes as well as those utilized in topical applications (see comments on cysteine protease below). In terms of cost, the ' world's most expensive drug ' is often considered to be the human lysosomal enzyme glucocerebrosidase, the only treatment for patients suffering from Gaucher's disease. At present this enzyme is purified from human placentae or CHO cells, and therefore the prospect of successful production in plants (Cramer et al., 1996) is an attractive option. Other orally-administered enzymes successfully produced in plants include pancreatic lipase-colipase complexes, enzymes required by patients with defective pancreatic activity .
One of the most interesting opportunities for the exploitation of plant enzymes for medical purposes is the use of pineapple cysteine proteases for the debridement of human skin prior to skin grafts. The present commercial product is based on a mixture of such proteases extracted from pineapple stem waste (Napper et al., 1994) and it is now proposed (Goodenough et al. pers. comm) to replace this product with an improved formulation based on the overexpression of a protease specifically modified to improve its activity at a pH closer to the value for human tissue.
Amongst the first commercial products produced by transgenic plants are the β-glucuronidase (GUS) from E. coli and the chicken egg-white avidin. These two compounds have been produced at high levels (5n7 % and 0n7%, respectively) in the kernels of transgenic corn (Kusnadi et al., 1998) and the purified proteins, used in diagnostic tests, are now marketed by Sigma Chemical Co. (St Louis, Missouri, USA).
Growth factors. Another group of plant-derived compounds with very high commercial value are the mammalian growth factors. These include the murine granulocytemacrophage colony stimulating factor (GM-CSF), human interleukin-2 (IL-2), IL-4, and the human epidermal growth factor (hEGF). Whereas the cytokines GM-CSF, IL-2, and IL-4 have been produced successfully in callus lines derived from transgenic tobacco (Lee et al., 1997 ; Magnuson et al., 1998) , hEGF has been produced in tobacco, kiwifruit and trifoliate orange (Kobayashi et al., 1996) as well as potato (Hooker et al., 1998) . Although many of these plant-derived factors have been shown to have biological activity, the need for detailed comparative analysis is demonstrated by data such as that obtained from human erythropoietin (EPO) produced in tobacco (Matsumoto et al., 1995) . This study revealed that the plant version was less glycosylated than the natural equivalent (see comments above on antibody glycosylation).
Other pharmaceutical compounds. Amongst many other plant-derived compounds of medical interest is the plant protein toxin ricin produced by the castor bean Ricinus communis. This toxin has found widespread applications as a potential therapeutic agent for many human diseases (e.g. linked to cancer specific antibodies) and in disease-model systems such as those involving apoptosis. Recently, it has been shown that transgenic tobacco expressing ricin could be used to generate stable cell cultures that provide a safe and simple means to produce properly processed recombinant ricin (Sehnke and Ferl, 1999) .
Other medically related compounds produced in plants include human haemoglobin (Dieryck et al., 1997) , and collagen .
CONCLUSION
This review has attempted to predict the range of plantderived transgenic products likely to be on the market in the year 2020. It has concentrated on those higher value products where the biosynthetic flexibility of plants has been exploited (Hitz, 1999) and it has not considered the modification of plants simply in order to improve their agronomic performance. It seems clear that the distinction between healthy food and pharmaceuticals will become blurred, with the arrival of so-called functional food (neutraceuticals). Of course, the accuracy of these predictions cannot be assured, and like all attempts at foresight there will be unexpected additions to the list of transgenic products, and many of the experimental materials presently undergoing field testing (Table 1) will never emerge as commercial products.
